Key takeaways:
A recent order from the federal judge overseeing the national Ozempic multidistrict litigation (MDL) has established a new standard for stomach paralysis claims. This decision directly impacts who may qualify to move forward with a lawsuit.
The court ruled that any plaintiff claiming to suffer from gastroparesis must have a diagnosis confirmed by objective medical evidence. This means a doctor’s clinical impression alone is not enough.
The diagnosis must be based on a properly performed gastric emptying study or a similar validated test. This ruling clarifies the evidence required for these specific claims. It sets a clear standard that attorneys must meet when filing a gastroparesis case on behalf of a client.
While this requirement may exclude some individuals who did not receive this specific testing, it strengthens the cases for those who have this definitive proof. It provides a solid, scientific foundation for claims moving forward in the litigation.
The drug manufacturers asked the court to dismiss many of the claims against them. Judge Karen Spencer Marston’s ruling was a mixed result. She dismissed claims related to design defects but allowed the central allegations to survive. This means the fight for accountability continues on key issues of corporate responsibility.
The court rejected the defense’s argument that their marketing was mere “puffery.” It found that plaintiffs had sufficiently identified specific safety claims that could have misled patients. Most importantly, claims that the manufacturers failed to warn about gastroparesis on the drug’s label will proceed.
While gastroparesis initially defined the litigation, a second and equally serious category of injuries has come into focus: permanent vision loss. These cases are now generating significant attention from both the legal and medical communities.
A growing number of plaintiffs are filing lawsuits in New Jersey state court alleging that Ozempic and Wegovy caused an irreversible condition called non-arteritic anterior ischemic optic neuropathy (NAION).
This condition involves a sudden loss of blood flow to the optic nerve, causing permanent blindness.
Over 30 plaintiffs have petitioned to consolidate these cases into a multicounty litigation (MCL) in New Jersey. Similar to a federal MDL, this process streamlines pretrial proceedings for efficiency and consistency.
The legal claims are being bolstered by emerging scientific research. A recent study in JAMA Ophthalmology found a potential link between these drugs and other serious eye conditions. These findings add to the body of evidence suggesting the vascular effects of these medications might have unintended consequences. Which is why many turn to a defective drugs & medical devices lawyer for guidance and accountability.
The legal strategy for holding manufacturers accountable is now advancing in two distinct arenas. This dual approach allows attorneys to pursue justice for different types of injuries in the venues best suited for those claims.
The federal MDL in Philadelphia remains the central hub for all stomach paralysis cases filed in federal courts across the country. With over 2,000 cases, this litigation will focus on what the companies knew about gastroparesis risks.
The push to create a separate, coordinated proceeding in New Jersey for NAION claims highlights the unique scientific evidence tied to vision loss. Pursuing these cases in state court may offer a different path to trial, potentially avoiding procedural hurdles that can slow down federal MDLs.
These recent developments provide both clarity and direction. For those with confirmed gastroparesis, the path forward in the federal MDL is more defined. For those who have suffered vision loss, the growing focus in New Jersey state courts offers a promising new avenue for accountability. The legal system is actively working through these complex scientific and factual issues.
The federal MDL, located in Philadelphia, consolidates all federal lawsuits alleging gastroparesis. The proposed New Jersey MCL would consolidate state-level lawsuits specifically alleging vision loss injuries like NAION. They are separate proceedings focused on different primary injuries.
No. If you have been diagnosed with gastroparesis or are suffering from its severe symptoms after taking Ozempic or Wegovy, you can still seek a legal consultation. An attorney can review your medical history and help you understand if additional testing might be necessary for your claim.
NAION is a sudden and permanent vision loss caused by a lack of blood flow to the optic nerve. Lawsuits allege that the vascular effects of drugs like Ozempic may contribute to or cause this condition, and that the manufacturer failed to warn of this risk.
Every state has a time limit for filing a personal injury claim, known as a statute of limitations. Because information about these severe side effects is still emerging, it is important to act quickly to protect your rights. Consulting with an attorney can help you determine the deadline for your situation.
The personal injury attorneys at Stark & Stark closely monitor all developments in the Ozempic and Wegovy lawsuits in both federal and state courts. If you or a family member suffered from severe gastroparesis or vision loss after using these medications in New Jersey or Pennsylvania, we are here to help.
Call us at 800.535.3425 for a free, confidential case evaluation.
Stark & Stark Attorneys Recognized as New Jersey “Super Lawyers” and “Rising Stars” in 2026
Stark & Stark is pleased to announce that 15 of its attorneys have been selected for inclusion in the list of 2026 New Jersey Super Lawyers,...Bruce Stern, Esq. Secures $1,000,000 Settlement in Motor Vehicle Collision Case
Bruce Stern, Esq. recently secured a $1,000,000 settlement in a motor vehicle collision case.* “This case highlights how quickly things can go...Deborah Dunn, Esq. Elected to Board of Directors for Angel Flight East
Stark & Stark is pleased to announce that Deborah Dunn, Esq., Shareholder and Civil Trial Attorney, has been elected to the Board of Directors...Michael Jordan, Esq. Joins the Board of the Lawrence Township Community Foundation
It is our pleasure to announce that Michael Jordan, Esq. has joined the board of the Lawrence Township Community Foundation, an organization...Joseph Lemkin, Esq. Named to ROI-NJ Influencers: Power List 2026 – Law
Stark & Stark is proud to share that Joseph Lemkin, Esq., Shareholder, has been named to the 2026 Influencers: Power List in the Law category...Joseph Cullen, Esq. and Nicole Durso, Esq. Secure $2,000,000 Settlement in Personal Injury Matter
Joseph Cullen, Esq. and Nicole Durso, Esq. recently secured a $2,000,000 settlement in a personal injury matter involving a pedestrian who was struck...James Creegan, Esq. Appointed to Board of The 200 Club of Mercer County
It is our pleasure to announce that James Creegan, Esq. has been appointed to the Board of Directors of The 200 Club of Mercer County, an...
